Site Search
ARCHIVED: NOT AVAILABLE FOR CREDIT
NIFTP and the Updated Bethesda System for Thyroid FNA
This presentation will discuss the development and underlying rationale for developing the terminology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Criteria for recognizing NIFTP in surgical pathology will be discussed as will the implications for NIFTP for thyroid FNA. Updates to the second edition of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) will be discussed including the impact of the NIFTP terminology.
Originally presented on February 12, 2020, in Park City, Utah.
Lecture Presenter
 | Jeffrey F. Krane, MD, PhD Professor of Pathology |
Dr. Krane joined the David Geffen School of Medicine at UCLA in June 2019 as a Professor of Pathology & Laboratory Medicine and the Director of the Cytopathology fellowship program. Previously, he was at Harvard Medical School and Brigham and Women’s Hospital in Boston for 26 years where he served as the Associate Director of Cytology and the Chief of Head and Neck Pathology. Dr. Krane has broad interests in neoplasia of the head and neck region. Particular areas of research interest are in salivary gland and thyroid cytopathology and HPV-associated malignancy of the head and neck region. Dr. Krane is a former member of the Executive Board of the American Society of Cytopathology and is currently an Associate Editor of Cancer Cytopathology. He has co-authored/contributed to several books including The Bethesda System for Reporting Thyroid Cytopathology and The Milan System for Reporting Salivary Gland Cytopathology.
Objectives
After this presentation, participants will be able to:
- Identify the criteria and rationale for developing NIFTP terminology
- Describe the implications of NIFTP for thyroid FNA
- Discuss updates to TBSRTC including those brought about by the adoption of the NIFTP terminology
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories